ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL.

Ibrahim Aldoss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.